Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/49239, first published .
Patient Acceptability of Symptom Screening and Patient Education Using a Chatbot for Autoimmune Inflammatory Diseases: Survey Study

Patient Acceptability of Symptom Screening and Patient Education Using a Chatbot for Autoimmune Inflammatory Diseases: Survey Study

Patient Acceptability of Symptom Screening and Patient Education Using a Chatbot for Autoimmune Inflammatory Diseases: Survey Study

Journals

  1. Wong R, Ming L, Raja Ali R. The Intersection of ChatGPT, Clinical Medicine, and Medical Education. JMIR Medical Education 2023;9:e47274 View
  2. Yoon J, Lee S, Cho S, Sung Y. Information and communication technology-based patient education for autoimmune inflammatory rheumatic diseases: A scoping review. Seminars in Arthritis and Rheumatism 2024;69:152575 View
  3. Lyu X, Li J, Li S. Approaches to Reach Trustworthy Patient Education: A Narrative Review. Healthcare 2024;12(23):2322 View
  4. Sloan M, Pollak T, D’Cruz D, Diment W, Bosley M, Lever E, Mann F, Sloan B, Brimicombe J, Morris S, Naughton F. A randomised controlled trial to assess the feasibility and acceptability of remote psychosocial and exercise interventions for people with lupus: The ADAPT feasibility trial. Rheumatology International 2025;45(10) View
  5. Shah N, Castellanos A, Chen Y, Piette J, Bucher A, Murphy S. A Scoping Review on Artificial Intelligence–Supported Interventions for Nonpharmacologic Management of Chronic Rheumatic Diseases. Arthritis Care & Research 2025 View
  6. Anand E, Ghersin I, Lingam G, Devlin K, Pelly T, Singer D, Tomlinson C, Munro R, Capstick R, Antoniou A, Hart A, Tozer P, Sahnan K, Lung P. Enhancing Patient Understanding of Perianal Fistula MRI Findings Using ChatGPT: A Randomized, Single Centre Study. Diagnostics 2025;16(1):72 View